ANUH PHARMA
|
The Current P/E Ratio of ANUH PHARMA is 18.79.
Share Price | ₹221.4 | Dec 11,2024 |
Market Cap | ₹1,109.2 Cr | |
Earnings-TTM | ₹59.0 Cr | TTM-Standalone Results |
Price/Earnings | 18.79x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of ANUH PHARMA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹1,109.2 Cr] as on Dec 11,2024
(/) Earnings [ ₹59.0 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 18.79x ]
Thus, for ANUH PHARMA , the investors are currently willing to pay 18.79 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ANUH PHARMA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ANUH PHARMA over the last five years.
Historical PE (Price/Earnings) ratio chart of ANUH PHARMA
PE Ratio Performance Analysis for ANUH PHARMA
- ANUH PHARMA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 14.35x.
- ANUH PHARMA 's operated at median p/e ratio of 14.09x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ANUH PHARMA 's p/e ratio peaked in Mar2024 at 20.49x.
- ANUH PHARMA 's p/e ratio hit its five-year low in Mar2020 of 10.21x.
How does ANUH PHARMA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
ANUH PHARMA | 59.02 | 18.79 | 1,109.2 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,136.50 | 39.10 | 435,407.0 |
CIPLA LTD | 4,485.22 | 26.18 | 117,443.0 |
DR REDDYS LABORATORIES LTD | 5,406.80 | 19.11 | 103,338.0 |
ZYDUS LIFESCIENCES LTD | 4,298.90 | 23.09 | 99,244.9 |
DIVIS LABORATORIES LTD | 1,836.00 | 85.78 | 157,489.0 |
MANKIND PHARMA LTD | 2,124.86 | 49.46 | 105,098.0 |
TORRENT PHARMACEUTICALS LTD | 1,802.00 | 63.38 | 114,202.0 |
LUPIN LTD | 2,651.94 | 36.97 | 98,055.1 |
AUROBINDO PHARMA LTD | 3,598.83 | 19.78 | 71,188.9 |
ABBOTT INDIA LTD | 1,284.66 | 47.75 | 61,336.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ANUH PHARMA 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.79x |
Max industry PE | 85.78x |
Median industry PE | 36.97x |
Average industry PE | 39.04x |
You may also like the below Video Courses